Evidence and Uncertainties Surrounding Renin-Guided Medical Therapy for Primary Aldosteronism

Am J Hypertens. 2023 Jul 14;36(8):428-430. doi: 10.1093/ajh/hpad034.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Aldosterone
  • Humans
  • Hyperaldosteronism* / diagnosis
  • Hyperaldosteronism* / drug therapy
  • Hyperaldosteronism* / physiopathology
  • Hypertension* / diagnosis
  • Hypertension* / drug therapy
  • Hypertension* / physiopathology
  • Mineralocorticoid Receptor Antagonists
  • Mineralocorticoids
  • Renin

Substances

  • Renin
  • Mineralocorticoid Receptor Antagonists
  • Mineralocorticoids
  • Aldosterone

Grants and funding